These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 7811617)
21. Importance and management of dyslipidemia in the metabolic syndrome. Menuet R; Lavie CJ; Milani RV Am J Med Sci; 2005 Dec; 330(6):295-302. PubMed ID: 16355014 [TBL] [Abstract][Full Text] [Related]
22. Lipid-lowering therapies, glucose control and incident diabetes: evidence, mechanisms and clinical implications. Zafrir B; Jain M Cardiovasc Drugs Ther; 2014 Aug; 28(4):361-77. PubMed ID: 24952127 [TBL] [Abstract][Full Text] [Related]
23. Fibrates and fish oil, but not corn oil, up-regulate the expression of the cholesteryl ester transfer protein (CETP) gene. Raposo HF; Patrício PR; Simões MC; Oliveira HC J Nutr Biochem; 2014 Jun; 25(6):669-74. PubMed ID: 24746832 [TBL] [Abstract][Full Text] [Related]
25. Trends in the Use of Nonstatin Lipid-Lowering Therapy Among Patients With Coronary Heart Disease: A Retrospective Cohort Study in the Medicare Population 2007 to 2011. Bittner V; Deng L; Rosenson RS; Taylor B; Glasser SP; Kent ST; Farkouh ME; Muntner P J Am Coll Cardiol; 2015 Oct; 66(17):1864-72. PubMed ID: 26493657 [TBL] [Abstract][Full Text] [Related]
26. [Pharmacy clinics. How I treat... A patient with hypertriglyceridemia]. Scheen AJ Rev Med Liege; 1995 Jun; 50(6):237-8. PubMed ID: 7617998 [No Abstract] [Full Text] [Related]
27. Statins: is there a need for alternative or adjunctive therapy? Shepherd J Br Heart J; 1995 Jul; 74(1):13. PubMed ID: 7662445 [No Abstract] [Full Text] [Related]
29. CORONARY EFFECT OF FIBRATES ON PROTEINS AND ENZYMES WHICH HYDROLYZE TRIACYLGLYCEROLS. Francik R; Kryczyk J; Francik S Acta Pol Pharm; 2016; 73(3):579-88. PubMed ID: 27476274 [TBL] [Abstract][Full Text] [Related]
31. Management of hypercholesterolaemia in postmenopausal women. Davidson MH; Maki KC; Karp SK; Ingram KA Drugs Aging; 2002; 19(3):169-78. PubMed ID: 12027776 [TBL] [Abstract][Full Text] [Related]
32. Choosing the right lipid-regulating agent. A guide to selection. Farmer JA; Gotto AM Drugs; 1996 Nov; 52(5):649-61. PubMed ID: 9118815 [TBL] [Abstract][Full Text] [Related]
33. [Fibrate and its perspective as a drug for metabolic syndrome]. Tada N Nihon Rinsho; 2006 Dec; 64 Suppl 9():622-6. PubMed ID: 17458293 [No Abstract] [Full Text] [Related]
34. [Diagnosis and treatment of severe hyperlipidemia]. Tonstad S; Leren TP; Ose L Tidsskr Nor Laegeforen; 1997 Nov; 117(29):4241-4. PubMed ID: 9441469 [TBL] [Abstract][Full Text] [Related]
35. Psychiatric adverse reactions with statins, fibrates and ezetimibe: implications for the use of lipid-lowering agents. Tatley M; Savage R Drug Saf; 2007; 30(3):195-201. PubMed ID: 17343428 [TBL] [Abstract][Full Text] [Related]